An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...

Cholesterol is often demonized as the main culprit behind heart disease, but the truth is, it is a lot more complicated than ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

LDL cholesterol is an important marker, but others such as ApoB, hs-CRP, and insulin resistance should not be ignored, shares Dr Kumar.

Editing your genes to eliminate bad cholesterol and a new discovery that could change the playbook for Alzheimer's. Here are ...

Did you know that about 40% of people who have high LDL cholesterol (the “bad” cholesterol) levels are unaware of their status? If your doctor has told you your LDL is high, consider yourself lucky to ...

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point ...

If your doctor has ever told you to "keep an eye on your numbers," here's good news: The rules around what’s considered high cholesterol have gotten clearer—and a little more personal. In March, the ...

The prevalence of US adults with severely elevated LDL cholesterol has declined in the past two decades, as has the percentage of those who are unaware of their high cholesterol levels and who remain ...

Treating elevated low-density lipoprotein cholesterol (LDL-C) in adults younger than 40 with statins is highly cost-effective in men, and intermediately cost-effective in women, a new report suggests.